ID: ALA5183090

Max Phase: Preclinical

Molecular Formula: C20H18O2

Molecular Weight: 290.36

Associated Items:

Representations

Canonical SMILES:  OC(COc1ccccc1)c1ccc(-c2ccccc2)cc1

Standard InChI:  InChI=1S/C20H18O2/c21-20(15-22-19-9-5-2-6-10-19)18-13-11-17(12-14-18)16-7-3-1-4-8-16/h1-14,20-21H,15H2

Standard InChI Key:  HOOSGAOCFDSESO-UHFFFAOYSA-N

Associated Targets(non-human)

Glutamate NMDA receptor 6467 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 290.36Molecular Weight (Monoisotopic): 290.1307AlogP: 4.47#Rotatable Bonds: 5
Polar Surface Area: 29.46Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.66CX Basic pKa: CX LogP: 4.56CX LogD: 4.56
Aromatic Rings: 3Heavy Atoms: 22QED Weighted: 0.75Np Likeness Score: -0.34

References

1. Karlov DS, Temnyakova NS, Vasilenko DA, Barygin OI, Dron MY, Zhigulin AS, Averina EB, Grishin YK, Grigoriev VV, Gabrel'yan AV, Aniol VA, Gulyaeva NV, Osipenko SV, Kostyukevich YI, Palyulin VA, Popov PA, Fedorov MV..  (2022)  Biphenyl scaffold for the design of NMDA-receptor negative modulators: molecular modeling, synthesis, and biological activity.,  13  (7.0): [PMID:35923717] [10.1039/d2md00001f]

Source